CA
FLGT icon

CoreCap Advisors’s Fulgent Genetics FLGT Stock Holding History

CoreCap Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03K Hold
50
– – ﹤0.01% 2688
2026
Q1 		$795 Hold
50
– – ﹤0.01% 2567
2025
Q4 		$1.31K Buy
+50
New +$1.3K ﹤0.01% 2553
2025
Q1 		– Sell
-20
Closed -$369 – 3190
2024
Q4 		$369 Buy
20
+8
+67% +$156 ﹤0.01% 2594
2024
Q3 		$261 Buy
+12
New +$268 ﹤0.01% 2456
2022
Q3 		– Sell
-164
Closed -$9K – 1062
2022
Q2 		$9K Buy
+164
New +$9.01K ﹤0.01% 1504
2022
Q1 		– Sell
-264
Closed -$27K – 1067
2021
Q4 		$27K Buy
+264
New +$23.2K ﹤0.01% 1218

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CoreCap Advisors's FLGT Position: Q2 2026 in Review

CoreCap Advisors held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 50 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2688.

CoreCap Advisors first reported a position in FLGT in Q4 2021 and has held it in 7 quarters since. The position peaked at $27K in Q4 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • CoreCap Advisors held 50 shares of Fulgent Genetics worth $1.03K as of Q2 2026.
  • CoreCap Advisors left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2688 holding.
  • CoreCap Advisors first reported a position in Fulgent Genetics in Q4 2021 and has held it in 7 quarters since.
  • CoreCap Advisors's Fulgent Genetics position peaked at $27K in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.